BROADCASTS.com

b'

We interrupt our normal FOAMcast episodes to bring you updates from COVID-19. *Our understanding of COVID-19 is rapidly developing and this may be out of date in days/weeks. So, check back for updates/fact check what you hear*

This episode reviews the NIAID trial, ACTT-1, on remdesivir vs placebo (Beigel et al)

Show notes:\\xa0FOAMcast.org

Thanks for listening,
Lauren Westafer and Jeremy Faust

*Recorded May 23, 2020